Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 35

Sort by

Sort Order Select

Journal Articles

Safe & Effective Reduced Intensity Conditioning Regimen in Patients with Dyskeratosis Congenita

Archana Ramgopal, DO, Beth Carella, DO, Paul Szabolcs, MD, Steven William Allen, MD BS, Jessie L. Barnum, MD

Blood (2020) 136 (Supplement 1): 3–4.

https://doi.org/10.1182/blood-2020-140621

Published: 2020

Journal Articles

Donor Leukocyte Infusion for Single Unit Umbilical Cord Blood Transplantation: 5% of Thawed Single Cord Blood Unit Refrozen on Day of Transplant Is Safe with Signals of Efficacy in Improving Donor Derived Immunity

Mark Vander Lugt, MD, Beth Carella, DO, Heather Stanczak, Xiaohua Chen, MD PhD, Paul Szabolcs, MD

Blood (2018) 132 (Supplement 1): 3414.

https://doi.org/10.1182/blood-2018-99-119261

Published: 2018

Journal Articles

Clonal Deletion Plays a Major Role to Achieve Immune Tolerance after Reduced Intensity Unrelated Donor Cord Blood Transplantation (UCBT)

Paul Szabolcs, MD, Xiaohua Chen, MD PhD, Mark Vander Lugt, MD, Memphis J Hill, BS

Blood (2016) 128 (22): 4584.

https://doi.org/10.1182/blood.V128.22.4584.4584

Published: 2016

Journal Articles

Enhancing Cytotoxicity of Autologous T Cells in AML By Blockade of CTLA-4 and PD-1

Kirsten Marie Boughan, DO, Xiaohua Chen, MD PhD, Paul Szabolcs, MD

Blood (2016) 128 (22): 4057.

https://doi.org/10.1182/blood.V128.22.4057.4057

Published: 2016

Journal Articles

Excellent Outcomes in Children and Young Adults Using Reduced-Intensity Conditioning for Patients with Inborn Errors of Immunity, Hematopoiesis, and Metabolism with Single-Unit Cord Blood or Bone Marrow

Mark Vander Lugt, MD, Hey Jin Chong, MD PhD, Xiaohua Chen, MDPhD, Randy M. Windreich, MD, Rakesh Goyal, MD MRCP, Maria Escolar, MD, Paul Szabolcs, MD

Blood (2015) 126 (23): 4329.

https://doi.org/10.1182/blood.V126.23.4329.4329

Published: 2015

Journal Articles

Distinct Pattern of Regulatory T Cell Reconstitution after Umbilical Cord Blood Transplantation in Pediatric Patients with Reduced Intensity Conditioning Regimen

Xiaohua Chen, MDPhD, Mark Vander Lugt, MD, Memphis J Hill, BS, Paul Szabolcs, MD

Blood (2015) 126 (23): 1951.

https://doi.org/10.1182/blood.V126.23.1951.1951

Published: 2015

Journal Articles

Characterization of Regulatory T Cell Reconstitution after Allogeneic Hematopoietic Cell Transplantation: Expansion Potential at 100 Days Predicts De Novo Graft-Versus-Host Disease By Six Months Post-Transplantation

Julie R. Boiko, MS, Annie Im, MD, Xiaohua Chen, MDPhD, Memphis J Hill, BS, Paul Szabolcs, MD

Blood (2015) 126 (23): 1932.

https://doi.org/10.1182/blood.V126.23.1932.1932

Published: 2015

Journal Articles

Generating AML-Specific Peripheral Blood Autologous Cytotoxic T-Lymphocytes (CTLs)

Rohtesh S. Mehta, MD MPH, MS, Xiaohua Chen, PhD, Antony Jeyaraj, PhD, Paul Szabolcs, MD

Blood (2014) 124 (21): 5806.

https://doi.org/10.1182/blood.V124.21.5806.5806

Published: 2014

Journal Articles

CD137 Expression Identifies Leukemia Specific CTL After In Vitro Priming Of Cord Blood T Cells

Jeyaraj Antony, PhD, Xiaohua Chen, PhD, Paul Szabolcs, MD

Blood (2013) 122 (21): 3266.

https://doi.org/10.1182/blood.V122.21.3266.3266

Published: 2013

Journal Articles

Multicenter Study of “off-the-Shelf” Third Party Virus-Specific T Cells (VSTs) to Treat Adenovirus (Adv), Cytomegalovirus (CMV) or Epstein Barr Virus (EBV) Infection After Hemopoietic Stem Cell Transplantation (HSCT)

Ann M. Leen, PhD, Catherine M. Bollard, MD, Adam M. Mendizabal, MS, Elizabeth J. Shpall, MD, Paul Szabolcs, MD, Joseph H. Antin, MD, Neena Kapoor, MD, Sung-Yun Pai, MD, Scott D. Rowley, MD, Partow Kebriaei, M.D., Bambi J. Grilley, Adrian P. Gee, PhD, Malcolm K. Brenner, MD, PhD, Cliona M. Rooney, PhD, Helen E. Heslop, MD

Blood (2012) 120 (21): 457.

https://doi.org/10.1182/blood.V120.21.457.457

Published: 2012

Journal Articles

IL-15 Induced Polyclonal CTL Generated From Expanded CBT Cells Against Leukemia Cell Lines Constitutes IFN-γ Producing Cells and TCRγδ Cells

Jeyaraj Antony, PhD, Xiaohua Chen, PhD, Paul Szabolcs, MD

Blood (2012) 120 (21): 1910.

https://doi.org/10.1182/blood.V120.21.1910.1910

Published: 2012

Journal Articles

Most Closely HLA-Matched Allogeneic Virus Specific Cytotoxic T-Lymphocytes (CTL) to Treat Persistent Reactivation or Infection with Adenovirus, CMV and EBV After Hemopoietic Stem Cell Transplantation (HSCT)

Ann M. Leen, PhD, Catherine M Bollard, MD, Adam M Mendizabal, Elizabeth J. Shpall, MD, Paul Szabolcs, MD, Joseph H. Antin, MD, Neena Kapoor, MD, Callie Heaton, Bambi J Grilley, Adrian P. Gee, PhD, Malcolm K. Brenner, MB, PhD, FRCP, FRCPath, Cliona M Rooney, PhD, Helen E. Heslop, MD

Blood (2010) 116 (21): 829.

https://doi.org/10.1182/blood.V116.21.829.829

Published: 2010

Journal Articles

Reduced Intensity Conditioning In Children Undergoing Unrelated Umbilical Cord Blood Transplantation for Non-Malignant Diseases: Preliminary Results Demonstrate a High Rate of Engraftment and Low Incidence of Gvhd

Suhag H Parikh, MD, Paul L Martin, MD, PhD, Timothy A Driscoll, Jennifer Baker, RN, Ketti Piersol, PNP, Jerelyn Moffet, PNP, Andre Stokhuyzen, PNP, Joanne Kurtzberg, MD, Paul Szabolcs, MD

Blood (2010) 116 (21): 3535.

https://doi.org/10.1182/blood.V116.21.3535.3535

Published: 2010

Journal Articles

A Comprehensive Comparison Immune Recovery In Adult Patients Following Allogeneic Umbilical Cord Blood, Matched Sibling and Matched Unrelated Donor Stem Cell Transplantation

Lun-Wei Chiou, MD, Junya Kanda, MD, Paul Szabolcs, MD, Gregory E. Sempowski, PhD, Jeffrey Hale, Donna Niedzwiecki, PhD, Gloria Broadwater, MS, Nelson J. Chao, MD, Mitchell E. Horwitz, MD

Blood (2010) 116 (21): 2313.

https://doi.org/10.1182/blood.V116.21.2313.2313

Published: 2010

Journal Articles

Transplantation Following Myeloablative Cytoreduction Results in Excellent Survival, Long-Term Engraftment, and Donor Chimerism in Children with Chronic Granulomatous Disease Across Donor and Graft Sources.

Priti Tewari, MD, Susan Wood, PNP, Paul L Martin, MD, PhD, Suhag H Parikh, MD, Paul Szabolcs, MD, Kristin M Page, MD, Timothy Driscoll, MD, Joanne Kurtzberg, MD, Vinod K. Prasad, MBBS, MD, MRCP,

Blood (2009) 114 (22): 3398.

https://doi.org/10.1182/blood.V114.22.3398.3398

Published: 2009

Journal Articles

Long-Term Survival and Late Deaths After Hematopoietic Stem Cell Transplantation for Primary Immunodeficiency Diseases and Inborn Errors of Metabolism.

Blood (2009) 114 (22): 3320.

https://doi.org/10.1182/blood.V114.22.3320.3320

Published: 2009

Journal Articles

Despite Absence of Measurable Immune Responses against Adenovirus in the First 100 Days After Unrelated Umbilical Cord Blood Transplant in Vitro amplification Strategies Can Unveil Hexon and Penton-Specific Immunity.

Ann M. Leen, PhD, Anne Christin, MD, Luciana C Marti, PhD, Jennifer H Baker, RN, Paul Szabolcs, MD

Blood (2009) 114 (22): 4640.

https://doi.org/10.1182/blood.V114.22.4640.4640

Published: 2009

Journal Articles

Detection and Ex Vivo Expansion of Anti-Viral T Cells Isolated From Recipients of Unrelated Umbilical Cord Blood Transplant.

Luciana C Marti, PhD, Ann M. Leen, PhD, Sylvia Janetzki, MD, Jennifer H Baker, RN, Paul Szabolcs, MD

Blood (2009) 114 (22): 2245.

https://doi.org/10.1182/blood.V114.22.2245.2245

Published: 2009

Journal Articles

Thymic Recovery and De Novo T Cell Production During the First Year After Unrelated Cord Blood Transplant (UCBT) Predicts Overall Survival: A Multivariate Analysis of 93 Patients Following Myeloablative Conditioning and a Single Unit Graft.

David A Wilfret, MD, Adam Mendizabal, Kristin M Page, MD, Mel Reese, Richard Vinesett, BS, Joanne Kurtzberg, MD, Paul Szabolcs, MD

Blood (2009) 114 (22): 1173.

https://doi.org/10.1182/blood.V114.22.1173.1173

Published: 2009

Journal Articles

Plasmacytoid CD123+ Dendritic Cell Recovery Is An Independent Predictor of Survival after Unrelated Cord Blood Transplant (UCBT).

Davi d A Wilfret, MD, Adam Mendizabal, Mel Reese, Richard Vinesett, Joanne Kurtzberg, MD, Paul Szabolcs, MD

Blood (2008) 112 (11): 2228.

https://doi.org/10.1182/blood.V112.11.2228.2228

Published: 2008

NARROW

Safe & Effective Reduced Intensity Conditioning Regimen in Patients with Dyskeratosis Congenita

Donor Leukocyte Infusion for Single Unit Umbilical Cord Blood Transplantation: 5% of Thawed Single Cord Blood Unit Refrozen on Day of Transplant Is Safe with Signals of Efficacy in Improving Donor Derived Immunity

Clonal Deletion Plays a Major Role to Achieve Immune Tolerance after Reduced Intensity Unrelated Donor Cord Blood Transplantation (UCBT)

Enhancing Cytotoxicity of Autologous T Cells in AML By Blockade of CTLA-4 and PD-1

Excellent Outcomes in Children and Young Adults Using Reduced-Intensity Conditioning for Patients with Inborn Errors of Immunity, Hematopoiesis, and Metabolism with Single-Unit Cord Blood or Bone Marrow

Distinct Pattern of Regulatory T Cell Reconstitution after Umbilical Cord Blood Transplantation in Pediatric Patients with Reduced Intensity Conditioning Regimen

Characterization of Regulatory T Cell Reconstitution after Allogeneic Hematopoietic Cell Transplantation: Expansion Potential at 100 Days Predicts De Novo Graft-Versus-Host Disease By Six Months Post-Transplantation

Generating AML-Specific Peripheral Blood Autologous Cytotoxic T-Lymphocytes (CTLs)

CD137 Expression Identifies Leukemia Specific CTL After In Vitro Priming Of Cord Blood T Cells

Multicenter Study of “off-the-Shelf” Third Party Virus-Specific T Cells (VSTs) to Treat Adenovirus (Adv), Cytomegalovirus (CMV) or Epstein Barr Virus (EBV) Infection After Hemopoietic Stem Cell Transplantation (HSCT)

IL-15 Induced Polyclonal CTL Generated From Expanded CBT Cells Against Leukemia Cell Lines Constitutes IFN-γ Producing Cells and TCRγδ Cells

Most Closely HLA-Matched Allogeneic Virus Specific Cytotoxic T-Lymphocytes (CTL) to Treat Persistent Reactivation or Infection with Adenovirus, CMV and EBV After Hemopoietic Stem Cell Transplantation (HSCT)

Reduced Intensity Conditioning In Children Undergoing Unrelated Umbilical Cord Blood Transplantation for Non-Malignant Diseases: Preliminary Results Demonstrate a High Rate of Engraftment and Low Incidence of Gvhd

A Comprehensive Comparison Immune Recovery In Adult Patients Following Allogeneic Umbilical Cord Blood, Matched Sibling and Matched Unrelated Donor Stem Cell Transplantation

Transplantation Following Myeloablative Cytoreduction Results in Excellent Survival, Long-Term Engraftment, and Donor Chimerism in Children with Chronic Granulomatous Disease Across Donor and Graft Sources.

Long-Term Survival and Late Deaths After Hematopoietic Stem Cell Transplantation for Primary Immunodeficiency Diseases and Inborn Errors of Metabolism.

Despite Absence of Measurable Immune Responses against Adenovirus in the First 100 Days After Unrelated Umbilical Cord Blood Transplant in Vitro amplification Strategies Can Unveil Hexon and Penton-Specific Immunity.

Detection and Ex Vivo Expansion of Anti-Viral T Cells Isolated From Recipients of Unrelated Umbilical Cord Blood Transplant.

Thymic Recovery and De Novo T Cell Production During the First Year After Unrelated Cord Blood Transplant (UCBT) Predicts Overall Survival: A Multivariate Analysis of 93 Patients Following Myeloablative Conditioning and a Single Unit Graft.

Plasmacytoid CD123+ Dendritic Cell Recovery Is An Independent Predictor of Survival after Unrelated Cord Blood Transplant (UCBT).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only